$2995 | Single User
$5990 | Site License
$8985 | Global License

China - Enterprise ICT Investment Trends 2020
[Lowest Price Guaranteed: $2,995]

Published by Global Data: 29 May 2020 | 261567 | In Stock
Related Topics: COVID , Investment

Introduction

China - Enterprise ICT Investment Trends 2020

Summary

Most survey respondents from China confirmed that technology purchase decisions in their enterprises are jointly taken by all parties involved.

According to the survey, most respondents from China said that their enterprises would see considerable reduction in their intended ICT budget for 2020 post the COVID-19 outbreak compared to what it was in the pre-COVID period.

With regards to IoT investments, ‘network sensors’, and ‘LPWAN’ will be the popular investment areas in IoT hardware, and IoT connectivity areas respectively for most enterprises in China in the next two years, while SCADA and IoT/M2M security will be the key IoT software investment area for enterprises in China over the next two years.

The survey also reveals that a higher percentage of ICT spending among enterprises in China will be spent ‘on running business as usual with existing ICT systems’ than the percentage of ICT spending that would be used for ‘transforming businesses with new ICT systems.

Scope

The survey report provides information and insights into ICT spending by enterprises in China -

- Insights of its ICT budget allocation by business function and key spending areas

- Enterprise ICT Budget Outlook for 2020

- Enterprise ICT Budget Allocations in 2020 vs. 2019, including the effect of COVID-19 on budget allocations

- Segment wise ICT budget allocation comparison between 2019 and 2021

Reasons to Buy

- Gain insights into Chinese enterprises ICT spending trends

- Gain insights into Chinese enterprises ICT budget allocation for 2020

- Gain insights into effect of COVID-19 on ICT budget of enterprises in China

- Gain insights into key technology priorities of the Chinese enterprises in allocating ICT budgets

Table of Contents
for China - Enterprise ICT Investment Trends 2020

  • Table of Contents

    Executive summary

    Key Findings

    Survey Demographics

    Enterprise ICT Budget Allocations - 2019

    Enterprise ICT Budget Outlook - 2020

    Enterprise ICT Budget Allocations - 2020 vs. 2019

    Segment ICT Budget Allocations - 2019 vs. 2020

    Future Outlook - Enterprise Technology Priorities

    Appendix

Additional Details

Publisher

Global Data

Publisher Information

Reference

261567 | GD0349CI

Number of Pages

39

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
China YCT International Group, Inc. (CYIG) - Financial and Strategic SWOT Analysis Review
SummaryChina YCT International Group Inc. (China YCT) is a pharmaceutical company. The company provi...
08 Nov 2015 by Global Data USD $300 More Info
China Biologic Products, Inc. (CBPO) - Financial and Strategic SWOT Analysis Review
SummaryChina Biologic Products, Inc. (CBP) is a plasma biopharmaceutical company that develops treat...
08 Nov 2015 by Global Data USD $300 More Info
China Resources Wandong Medical Equipment Co., Ltd. (600055) - Financial and Strategic SWOT Analysis Review
SummaryChina Resources Wandong Medical Equipment Co., Ltd. (CR Wandong), a subsidiary of Beijing Pha...
08 Nov 2015 by Global Data USD $300 More Info
China Grand Pharmaceutical and Healthcare Holdings Limited (512) - Financial and Strategic SWOT Analysis Review
SummaryChina Grand Pharmaceutical and Healthcare Holdings Limited (China Grand) is a pharmaceutical ...
08 Nov 2015 by Global Data USD $300 More Info
Anxin-China Holdings Limited (1149) - Financial and Strategic SWOT Analysis Review
SummaryAnxin-China Holdings Limited. (Anxin-China) is a safety solution providing company that focus...
08 Nov 2015 by Global Data USD $300 More Info
China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis Review
SummaryChina Medical System Holdings Limited (CMS) is a pharmaceutical service provider that include...
08 Nov 2015 by Global Data USD $300 More Info
China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic SWOT Analysis Review
SummaryChina Shineway Pharmaceutical Group Limited (China Shineway), a subsidiary of Shineway Pharma...
08 Nov 2015 by Global Data USD $300 More Info
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis Review
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a ...
08 Nov 2015 by Global Data USD $300 More Info
Inside China’s Pharma Sales Force – insights from the frontline
IntroductionIn 2011, China’s pharmaceutical sales force exceeded that of the U.S. for the first time...
01 Jul 2013 by FirstWord Pharma USD $695 More Info
Inside China’s Healthcare Reforms: Opportunities for Multinational Pharma
IntroductionIn 2009, China’s government announced plans to invest RMB1.13 trillion (0 billion) in...
01 Jun 2012 by FirstWord Pharma USD $995 More Info

This report is published by Global Data

Download Free Report Summary PDF

China - Enterprise ICT Investment Trends 2020 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...